These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32948302)

  • 21. Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
    Balestra GM; Mik EG; Eerbeek O; Specht PA; van der Laarse WJ; Zuurbier CJ
    Respir Res; 2015 Feb; 16(1):6. PubMed ID: 25645252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Intervention of Tongxinluo () on Right Ventricular Function Assessed by Echocardiography in Rats with Pulmonary Arterial Hypertension Induced by Monocrotaline.
    Gao L; Li SD; Zhang Y; Liu Y; Yang MH
    Chin J Integr Med; 2020 Dec; 26(12):913-920. PubMed ID: 32418178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension.
    Sun Y; Wan W; Zhao X; Han X; Ye T; Chen X; Ran Q; Wang X; Liu X; Qu C; Shi S; Zhang C; Yang B
    Bioengineered; 2022 Apr; 13(4):10843-10856. PubMed ID: 35473584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tanshinone IIA sulfonate upregulated pulmonary artery smooth muscle peroxisome proliferator-activated receptor γ expression in monocrotaline induced pulmonary hypertension rat].
    Jiang Q; Chen Y; Chen X; Zhang J; Lu W; Wang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 May; 37(5):360-4. PubMed ID: 25011512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].
    Li XW; Gao YX; Li S; Yang JR
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1355-61. PubMed ID: 26281561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G; Wang X; Li Y; He L
    Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BK
    Ferraz AP; Seara FAC; Baptista EF; Barenco TS; Sottani TBB; Souza NSC; Domingos AE; Barbosa RAQ; Takiya CM; Couto MT; Resende GO; Campos de Carvalho AC; Ponte CG; Nascimento JHM
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):719-732. PubMed ID: 33245463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective Effect of Resistance Exercise on Left Ventricular Remodeling Associated with Monocrotaline-Induced Pulmonary Arterial Hypertension.
    Oliveira-Junior SA; Ogura AY; Carvalho MR; Martinez PF
    Arq Bras Cardiol; 2022 Oct; 119(4):585-586. PubMed ID: 36287413
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploration of the Notch3-HES5 signal pathway in monocrotaline-induced pulmonary hypertension using rat model.
    Chen X; Zhou W; Hu Q; Huang L
    Congenit Heart Dis; 2019 May; 14(3):396-402. PubMed ID: 30811836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chrysin Alleviates Monocrotaline-Induced Pulmonary Hypertension in Rats Through Regulation of Intracellular Calcium Homeostasis in Pulmonary Arterial Smooth Muscle Cells.
    Dong F; Zhang J; Chen X; Zhang S; Zhu L; Peng Y; Guo Z
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):596-602. PubMed ID: 32168153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted delivery of pulmonary arterial endothelial cells overexpressing interleukin-8 receptors attenuates monocrotaline-induced pulmonary vascular remodeling.
    Fu J; Chen YF; Zhao X; Creighton JR; Guo Y; Hage FG; Oparil S; Xing DD
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1539-47. PubMed ID: 24790141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Puerarin-V prevents the progression of hypoxia- and monocrotaline-induced pulmonary hypertension in rodent models.
    Chen D; Zhang HF; Yuan TY; Sun SC; Wang RR; Wang SB; Fang LH; Lyu Y; Du GH
    Acta Pharmacol Sin; 2022 Sep; 43(9):2325-2339. PubMed ID: 35190697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formononetin attenuates monocrotaline‑induced pulmonary arterial hypertension via inhibiting pulmonary vascular remodeling in rats.
    Cai C; Xiang Y; Wu Y; Zhu N; Zhao H; Xu J; Lin W; Zeng C
    Mol Med Rep; 2019 Dec; 20(6):4984-4992. PubMed ID: 31702810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
    Chang CJ; Huang CC; Chen PR; Lai YJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N; Zhao X; Xiang Y; Ye S; Huang J; Hu W; Lv L; Zeng C
    Int J Cardiol; 2016 Oct; 221():587-96. PubMed ID: 27420584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats.
    Lu GF; Geng F; Deng LP; Lin DC; Huang YZ; Lai SM; Lin YC; Gui LX; Sham JSK; Lin MJ
    Hypertension; 2022 Nov; 79(11):2465-2479. PubMed ID: 35997022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity.
    Varshney R; Ali Q; Wu C; Sun Z
    Hypertension; 2016 Nov; 68(5):1255-1263. PubMed ID: 27672025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.